DIA477.78-1.39 -0.29%
SPY674.07-1.95 -0.29%
QQQ603.23-2.86 -0.47%

A Look At Dentsply Sirona (XRAY) Valuation After Soft Growth And Diminishing Returns Concerns

Simply Wall St·03/30/2026 08:11:47
Listen to the news

DENTSPLY SIRONA (XRAY) is back in focus after recent coverage highlighted soft constant currency revenue growth and diminishing returns on capital, putting management’s past and current decisions under a brighter spotlight for investors.

See our latest analysis for DENTSPLY SIRONA.

The recent concerns around soft constant currency revenue growth and weaker returns on capital sit against a share price of US$11.47 and a 1 month share price return of a 22% decline, with a 1 year total shareholder return of a 20.3% decline and a 5 year total shareholder return of an 80.14% decline, indicating that longer term momentum has been fading.

If this has you rethinking where growth might come from in healthcare, it could be worth broadening your watchlist with a curated set of 33 healthcare AI stocks

With the share price under pressure, a reported loss of US$598 million and an intrinsic value estimate that sits above where the stock trades today, you have to ask: is there a mispriced recovery story here, or is the market already discounting future growth?

Most Popular Narrative: 74.8% Undervalued

According to the most followed narrative, DENTSPLY SIRONA's fair value of $45.50 sits well above the last close at $11.47, which puts a spotlight on what might be driving such a wide gap.

Dentsply Sirona operates in a corner of healthcare that rarely attracts hype but consistently demands precision. As one of the world's largest dental equipment and consumables providers, the company sits upstream from patient demand, selling to dental practices rather than consumers. That position shapes everything about its business, from revenue stability to growth expectations.

Read the complete narrative.

The narrative, according to yiannisz, leans heavily on durable dental demand, recurring consumables revenue, and a business model built around long product cycles and practice level economics, all feeding into optimistic assumptions on future profitability and margins without spelling out the exact path in the headline numbers.

Result: Fair Value of $45.50 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, you also need to weigh risks such as the recent US$598 million loss and soft constant currency revenue growth, which could challenge the durability story that investors focus on.

Find out about the key risks to this DENTSPLY SIRONA narrative.

Next Steps

With sentiment clearly mixed, it helps to look past the headlines and test the data yourself. Pay attention to both the potential upside and the warning signs highlighted in the 4 key rewards and 1 important warning sign

Looking for more investment ideas?

If DENTSPLY SIRONA is on your radar, do not stop there. Broaden your opportunity set with focused stock ideas that match the kind of portfolio you want to build.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Contact Us

Contact Number :+852 3852 8500
Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hk
Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hk
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2026 Webull Securities Limited. All rights reserved.